203 related articles for article (PubMed ID: 16690718)
1. Identification of novel small molecule inhibitors of amyloid precursor protein synthesis as a route to lower Alzheimer's disease amyloid-beta peptide.
Utsuki T; Yu QS; Davidson D; Chen D; Holloway HW; Brossi A; Sambamurti K; Lahiri DK; Greig NH; Giordano T
J Pharmacol Exp Ther; 2006 Aug; 318(2):855-62. PubMed ID: 16690718
[TBL] [Abstract][Full Text] [Related]
2. The experimental Alzheimer's disease drug posiphen [(+)-phenserine] lowers amyloid-beta peptide levels in cell culture and mice.
Lahiri DK; Chen D; Maloney B; Holloway HW; Yu QS; Utsuki T; Giordano T; Sambamurti K; Greig NH
J Pharmacol Exp Ther; 2007 Jan; 320(1):386-96. PubMed ID: 17003227
[TBL] [Abstract][Full Text] [Related]
3. The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5'-untranslated region.
Venti A; Giordano T; Eder P; Bush AI; Lahiri DK; Greig NH; Rogers JT
Ann N Y Acad Sci; 2004 Dec; 1035():34-48. PubMed ID: 15681799
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of two hexahydropyrroloindole carbamate-based anticholinesterase drugs on the amyloid beta protein pathway involved in Alzheimer's disease.
Lahiri DK; Alley GM; Tweedie D; Chen D; Greig NH
Neuromolecular Med; 2007; 9(2):157-68. PubMed ID: 17627035
[TBL] [Abstract][Full Text] [Related]
5. Neurotrophic and neuroprotective actions of (-)- and (+)-phenserine, candidate drugs for Alzheimer's disease.
Lilja AM; Luo Y; Yu QS; Röjdner J; Li Y; Marini AM; Marutle A; Nordberg A; Greig NH
PLoS One; 2013; 8(1):e54887. PubMed ID: 23382994
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors.
Darreh-Shori T; Hosseini SM; Nordberg A
J Alzheimers Dis; 2014; 39(2):423-40. PubMed ID: 24217282
[TBL] [Abstract][Full Text] [Related]
7. FDA-preapproved drugs targeted to the translational regulation and processing of the amyloid precursor protein.
Morse LJ; Payton SM; Cuny GD; Rogers JT
J Mol Neurosci; 2004; 24(1):129-36. PubMed ID: 15314261
[TBL] [Abstract][Full Text] [Related]
8. A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity.
Hashimoto Y; Matsuoka M
J Neurochem; 2014 Jul; 130(2):291-300. PubMed ID: 24646423
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of the novel γ-secretase modulator AS2715348, a potential therapy for Alzheimer's disease, in rodents and nonhuman primates.
Mitani Y; Akashiba H; Saita K; Yarimizu J; Uchino H; Okabe M; Asai M; Yamasaki S; Nozawa T; Ishikawa N; Shitaka Y; Ni K; Matsuoka N
Neuropharmacology; 2014 Apr; 79():412-9. PubMed ID: 24373902
[TBL] [Abstract][Full Text] [Related]
10. Cholinesterase inhibitors, beta-amyloid precursor protein and amyloid beta-peptides in Alzheimer's disease.
Lahiri DK; Farlow MR; Hintz N; Utsuki T; Greig NH
Acta Neurol Scand Suppl; 2000; 176():60-7. PubMed ID: 11273593
[TBL] [Abstract][Full Text] [Related]
11. Acetylcholinesterase inhibitors increase ADAM10 activity by promoting its trafficking in neuroblastoma cell lines.
Zimmermann M; Gardoni F; Marcello E; Colciaghi F; Borroni B; Padovani A; Cattabeni F; Di Luca M
J Neurochem; 2004 Sep; 90(6):1489-99. PubMed ID: 15341532
[TBL] [Abstract][Full Text] [Related]
12. Heat shock alters Alzheimer's beta amyloid precursor protein expression in human endothelial cells.
Ciallella JR; Rangnekar VV; McGillis JP
J Neurosci Res; 1994 Apr; 37(6):769-76. PubMed ID: 8046777
[TBL] [Abstract][Full Text] [Related]
13. Chloroquine and chloroquinoline derivatives as models for the design of modulators of amyloid Peptide precursor metabolism.
Melnyk P; Vingtdeux V; Burlet S; Eddarkaoui S; Grosjean ME; Larchanché PE; Hochart G; Sergheraert C; Estrella C; Barrier M; Poix V; Plancq P; Lannoo C; Hamdane M; Delacourte A; Verwaerde P; Buée L; Sergeant N
ACS Chem Neurosci; 2015 Apr; 6(4):559-69. PubMed ID: 25611616
[TBL] [Abstract][Full Text] [Related]
14. From anti-Parkinson's drug rasagiline to novel multitarget iron chelators with acetylcholinesterase and monoamine oxidase inhibitory and neuroprotective properties for Alzheimer's disease.
Zheng H; Amit T; Bar-Am O; Fridkin M; Youdim MB; Mandel SA
J Alzheimers Dis; 2012; 30(1):1-16. PubMed ID: 22387411
[TBL] [Abstract][Full Text] [Related]
15. An overview of phenserine tartrate, a novel acetylcholinesterase inhibitor for the treatment of Alzheimer's disease.
Greig NH; Sambamurti K; Yu QS; Brossi A; Bruinsma GB; Lahiri DK
Curr Alzheimer Res; 2005 Jul; 2(3):281-90. PubMed ID: 15974893
[TBL] [Abstract][Full Text] [Related]
16. Reduction of iron-regulated amyloid precursor protein and beta-amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease.
Reznichenko L; Amit T; Zheng H; Avramovich-Tirosh Y; Youdim MB; Weinreb O; Mandel S
J Neurochem; 2006 Apr; 97(2):527-36. PubMed ID: 16539659
[TBL] [Abstract][Full Text] [Related]
17. Development of multifunctional, heterodimeric isoindoline-1,3-dione derivatives as cholinesterase and β-amyloid aggregation inhibitors with neuroprotective properties.
Guzior N; Bajda M; Skrok M; Kurpiewska K; Lewiński K; Brus B; Pišlar A; Kos J; Gobec S; Malawska B
Eur J Med Chem; 2015 Mar; 92():738-49. PubMed ID: 25621991
[TBL] [Abstract][Full Text] [Related]
18. Memantine treatment decreases levels of secreted Alzheimer's amyloid precursor protein (APP) and amyloid beta (A beta) peptide in the human neuroblastoma cells.
Ray B; Banerjee PK; Greig NH; Lahiri DK
Neurosci Lett; 2010 Feb; 470(1):1-5. PubMed ID: 19948208
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with β-amyloid anti-aggregation properties and beneficial effects on memory in vivo.
Więckowska A; Więckowski K; Bajda M; Brus B; Sałat K; Czerwińska P; Gobec S; Filipek B; Malawska B
Bioorg Med Chem; 2015 May; 23(10):2445-57. PubMed ID: 25868744
[TBL] [Abstract][Full Text] [Related]
20. Acetylcholinesterase inhibitors: novel activities of old molecules.
Racchi M; Mazzucchelli M; Porrello E; Lanni C; Govoni S
Pharmacol Res; 2004 Oct; 50(4):441-51. PubMed ID: 15304241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]